Centrifugal Blood Pumps Market Size & Share by Type (Electronic and Mechanical), by End-Use (Hospitals, Ambulatory Surgical Centres, Specialty Clinics and other end-uses), Regional Forecast, Industry Players, Growth Statistics Report 2023-2032

Market Outlook:

Centrifugal Blood Pumps Market size surpassed USD 68.59 Million in 2022 and is poised to reach USD 169.73 Million, growing at over 8.28% CAGR between 2023 and 2032. The market valuation of centrifugal blood pumps is projected to increase due to various factors such as rising prevalence of cardiovascular diseases, advancements in technology, growing demand for minimally invasive surgical procedures, and increasing elderly population worldwide.

• Base Year Value (2022): USD 68.59 Million
• CAGR (2023-2032): 8.28%
• Forecast Year Value (2032): USD 169.73 Million
• Historical Data Period: 2019-2021
• Largest Region: North America
• Forecast Period: 2023-2032

Market Dynamics:

Growth Drivers & Opportunities:

1. Increasing Prevalence of Cardiovascular Diseases: The rising incidence of cardiovascular diseases, including heart failure and coronary artery diseases, is driving the demand for centrifugal blood pumps. These pumps assist in the management of heart failure and provide temporary circulatory support during cardiac surgeries, thereby contributing to market growth.

2. Technological Advancements: Continuous advancements in technology have led to the development of innovative centrifugal blood pumps with improved outcomes and reduced complications. These advancements, such as the introduction of magnetically levitated centrifugal blood pumps, are expected to fuel market growth over the forecast period.

3. Minimally Invasive Surgical Procedures: There is a growing preference for minimally invasive surgical procedures due to their benefits, such as reduced post-operative recovery time, decreased hospital stay, and improved patient outcomes. Centrifugal blood pumps play a crucial role in these procedures, further driving market growth.

4. Increasing Elderly Population: The global population is aging rapidly, leading to a higher incidence of cardiovascular diseases among the elderly population. This demographic shift is expected to increase the demand for centrifugal blood pumps, thereby propelling market growth.

Report Scope

Report Coverage	Details
Segments Covered	Type, End-Use, Region
Regions Covered	• North America (United States, Canada, Mexico)   • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe)   Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC)   • Latin America (Argentina, Brazil, Rest of South America)   • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Medtronic Plc, Thoratec, Terumo, Qura Srl, Braile Biomedica., LivaNova, PLC, XENIOS AG, Getinge AB

 

Industry Restraints & Challenges:

1. High Cost of Centrifugal Blood Pumps: The high cost associated with centrifugal blood pumps may hinder their adoption, particularly in developing countries with budget constraints. The substantial investment required for purchasing these devices and subsequent maintenance can potentially limit market growth.

2. Risks Associated with Centrifugal Blood Pumps: Although centrifugal blood pumps offer numerous benefits, they are not without risks. Complications such as bleeding, infection, device malfunction, and thrombus formation are a few potential challenges associated with the use of these pumps, which may restrict market growth.

3. Limited Reimbursement Policies: In some regions, the lack of adequate reimbursement policies for centrifugal blood pumps may affect their adoption. The absence of reimbursement or limited coverage can pose financial burdens on patients and healthcare facilities, deterring market growth.

In conclusion, the global centrifugal blood pumps market is poised for significant growth driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements, demand for minimally invasive procedures, and the growing elderly population. However, challenges related to the high cost of pumps, associated risks, and limited reimbursement policies may restrict market growth to some extent.

Regional Forecast:

North America:

The North America region is anticipated to dominate the centrifugal blood pumps market during the forecast period. The presence of advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and increasing investments in research and development are some of the factors driving the market growth in this region. Furthermore, favorable reimbursement policies and the introduction of innovative technologies in the healthcare sector contribute to the growth of the centrifugal blood pumps market in North America.

Asia Pacific:

The Asia Pacific region is expected to exhibit significant growth in the centrifugal blood pumps market. Factors such as the rising geriatric population, increasing healthcare expenditure, and growing awareness about advanced medical devices contribute to the market growth. Additionally, the demand for better healthcare facilities and the presence of a large patient pool further enhance the market prospects in this region.

Europe:

Europe is projected to hold a substantial share in the centrifugal blood pumps market. The presence of well-established healthcare infrastructure, the high prevalence of cardiovascular diseases, and technological advancements are some of the key factors driving the market growth in this region. Moreover, the increasing adoption of centrifugal blood pumps in heart surgeries and the development of innovative medical devices by major market players contribute to the growth of the market in Europe.

Segmentation Analysis:

1. Sub-Segment: Continuous Flow Centrifugal Blood Pumps

Continuous flow centrifugal blood pumps are expected to witness significant growth in the market. These pumps provide continuous blood flow, thereby offering improved hemodynamic stability and reduced likelihood of complications during cardiac surgeries. The continuous flow centrifugal blood pumps segment is further expected to be driven by factors such as their compact size, ease of use, and ability to deliver precise flow rates. Additionally, these pumps have shown promising outcomes in patients with end-stage heart failure, further propelling their demand in the market.

Competitive Landscape:

The centrifugal blood pumps market is highly competitive and characterized by the presence of several key players. Some of the prominent market players include:

1. Medtronic

2. Terumo Corporation

3. Abbott Laboratories

4. Getinge AB

5. LivaNova PLC

6. Fresenius Medical Care AG & Co. KGaA

7. Abiomed Inc.

8. BiVACOR Inc.

9. ELITechGroup

10. Calon Cardio-Technology Ltd.

These companies are focusing on strategic collaborations, mergers and acquisitions, and research and development activities to strengthen their market position. They are also investing in technological advancements to develop innovative centrifugal blood pumps and expand their product offerings. The competitive landscape of the centrifugal blood pumps market is expected to witness intense competition and further technological advancements in the coming years.